Antitumor activity of the combination of an HSP90 inhibitor and a PI3K
- This topic has 0 replies, 1 voice, and was last updated 10 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.
” Our data suggest simultaneous targeting of the PI3K/mTOR and HSP pathways for CCA treatment.”
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.